X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Dr. Reddy's Laboratories Ltd.
BSE CODE: 500124   |   NSE CODE: DRREDDY   |   ISIN CODE : INE089A01031   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 1194.55
-19.4 ( -1.6% )
 
Prev Close ( Rs.)
1213.95
Open ( Rs.)
1175.05
 
High ( Rs.)
1207.20
Low ( Rs.)
1175.00
 
Volume
64949
Week Avg.Volume
61992
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1195.35
-18.1 ( -1.49% )
 
Prev Close ( Rs.)
1213.45
Open ( Rs.)
1174.90
 
High ( Rs.)
1206.70
Low ( Rs.)
1172.50
 
Volume
2121476
Week Avg.Volume
1741983
 
52 WK High-Low Range(Rs.)
1074
1421.49
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)260.31  156.83  97.55  131.39  176.76  
   CEPS(Rs)63.76  42.45  29.30  36.31  44.85  
   DPS(Rs)40.00  40.00  30.00  25.00  25.00  
   Book NAV/Share(Rs)1445.41  1220.20  1093.32  1013.05  907.83  
   Tax Rate(%)25.03  32.42  27.01  28.46  -5.83  
Margin Ratios          
   Core EBITDA Margin(%)30.42  24.85  18.01  23.50  24.22  
   EBIT Margin(%)29.84  22.89  15.70  23.24  23.83  
   Pre Tax Margin(%)29.72  22.79  15.44  22.89  23.42  
   PAT Margin (%)22.29  15.40  11.27  16.38  24.79  
   Cash Profit Margin (%)27.29  20.85  16.92  22.63  31.45  
Performance Ratios          
   ROA(%)15.58  10.48  7.08  10.87  16.73  
   ROE(%)19.54  13.57  9.26  13.69  21.22  
   ROCE(%)25.52  18.91  11.68  17.81  18.58  
   Asset Turnover(x)0.70  0.68  0.63  0.66  0.68  
   Sales/Fixed Asset(x)1.24  1.19  1.12  1.18  1.19  
   Working Capital/Sales(x)1.59  1.84  1.93  2.09  2.00  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.81  0.84  0.89  0.85  0.84  
   Receivable days83.48  99.35  114.34  119.20  128.69  
   Inventory Days66.15  68.76  78.14  68.49  64.77  
   Payable days130.85  115.51  102.62  99.93  100.38  
Valuation Parameters          
   PER(x)23.65  29.47  44.14  34.37  17.63  
   PCE(x)19.31  21.77  29.39  24.87  13.90  
   Price/Book(x)4.26  3.79  3.94  4.46  3.43  
   Yield(%)0.65  0.87  0.70  0.55  0.80  
   EV/Net Sales(x)5.25  4.50  4.99  5.60  4.49  
   EV/Core EBITDA(x)15.06  15.90  23.35  18.97  14.73  
   EV/EBIT(x)17.59  19.68  31.75  24.08  18.85  
   EV/CE(x)4.08  3.72  3.50  4.11  3.20  
   M Cap / Sales5.27  4.54  4.97  5.63  4.37  
Growth Ratio          
   Net Sales Growth(%)14.86  17.75  7.91  12.65  11.53  
   Core EBITDA Growth(%)41.25  56.24  -21.88  9.00  42.34  
   EBIT Growth(%)49.71  71.67  -27.11  9.89  60.66  
   PAT Growth(%)66.18  60.97  -25.76  -25.57  129.99  
   EPS Growth(%)65.98  60.77  -25.76  -25.66  129.72  
Financial Stability Ratios          
   Total Debt/Equity(x)0.03  0.00  0.12  0.07  0.10  
   Current Ratio(x)3.21  3.08  2.23  2.40  2.42  
   Quick Ratio(x)2.49  2.40  1.68  1.78  1.89  
   Interest Cover(x)266.66  229.76  59.52  66.44  59.07  
   Total Debt/Mcap(x)0.01  0.00  0.03  0.02  0.03